Hypnotics and Depression Risk
Author Information
Author(s): Daniel F. Kripke
Primary Institution: The Scripps Clinic Sleep Center
Hypothesis
Does the use of hypnotics increase the risk of depression compared to placebo?
Conclusion
Hypnotics are associated with a higher incidence of depression compared to placebo, suggesting they may not be suitable for individuals at risk of depression.
Supporting Evidence
- 2.0% of patients using hypnotics developed depression compared to 0.9% using placebo.
- The risk ratio for developing depression when using hypnotics was 2.1.
- Data was compiled from FDA New Drug Application documents.
Takeaway
Using sleeping pills might make you feel sadder instead of helping you sleep better.
Methodology
The study compiled data from FDA-approved trials comparing the incidence of depression in patients using hypnotics versus those using placebo.
Potential Biases
The data from FDA may be incomplete and potentially biased due to lack of comprehensive trial details.
Limitations
The data quality was insufficient for formal meta-analysis, and there were gaps in information regarding dropout rates and definitions of depression.
Participant Demographics
Patients in randomized controlled trials for four hypnotics.
Statistical Information
P-Value
0.002
Confidence Interval
1.3–3.3
Statistical Significance
p < 0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website